Watching other people reap the benefits of GLP-1s may trigger a little FOMO if you have type 1 diabetes. While these medications still aren’t approved for people with T1D, that gap may finally be starting to close. Here’s the latest research, potential benefits, and real reasons to be optimistic.
read more →
Trying to determine how much insulin to dose for a meal often ends up being a wild-ass guess. After using Afrezza for over ten years, Dr. E has a few tricks up his sleeve. Discover how Afrezza’s ultra-fast action can give you (or your kids) more flexibility with fewer mealtime dosing dilemmas.
read more →
It’s no a secret that a significant number of adults with type 1 diabetes are being misdiagnosed every year. But why is it happening? In our latest article we explore the most missed diagnosis in diabetes, and share the tests that can give you the answers you need.
read more →
Celiac disease is a serious autoimmune condition that can occur more often in people with type 1 diabetes. Find out how T1D and celiac are connected, why screening is important, and what to do if you do have a gluten sensitivity.
read more →
2026 is gearing up to be another milestone year in diabetes innovations. From continuous ketone monitoring to once-weekly insulin and new GLP-1 combinations like the “Triple G”, it should be an exciting year! Here are the biggest advancements coming down the pike.
read more →
